Create Free Account

By creating account you will get access to hot stocks & personalised emails

Estia Health Ltd

Healthcare AU EHE

NoneAUD
-(-%)

Last update at 2024-01-11T05:45:08.362937Z

Day Range

--
LowHigh

52 Week Range

1.833.08
LowHigh

Fundamentals

  • Previous Close 3.08
  • Market Cap805.54M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield5.10%
  • EBITDA108.33M
  • Revenue TTM754.30M
  • Revenue Per Share TTM2.92
  • Gross Profit TTM 169.47M
  • Diluted EPS TTM-0.13

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -43.37300M -73.55800M 9.06M -108.84500M 57.83M
Minority interest - - - - -
Net income -33.89800M -52.36200M 6.00M -116.90900M 41.29M
Selling general administrative 579.92M 529.67M 476.70M 452.86M 431.48M
Selling and marketing expenses 1.50M 1.31M 1.33M 1.42M 0.92M
Gross profit 169.47M 146.37M 140.46M 162.09M 585.99M
Reconciled depreciation 125.93M 105.35M 42.26M 39.12M 28.72M
Ebit 16.33M -29.09800M 57.39M 85.89M 65.33M
Ebitda 142.26M 76.25M 99.65M 125.01M 94.05M
Depreciation and amortization 125.93M 105.35M 42.26M 39.12M 28.72M
Non operating income net other - - - - -
Operating income -13.26600M 0.29M 61.83M 88.39M 65.33M
Other operating expenses 750.86M 700.28M 590.54M 695.89M 520.74M
Interest expense 47.70M 44.41M 47.39M 50.16M 7.06M
Tax provision -9.47500M -21.19600M 3.06M 8.06M 16.54M
Interest income 46.81M 0.02M 2.93M 3.94M 1.52M
Net interest income -48.87000M -46.29800M -48.81200M -50.16200M -6.99000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -9.47500M -21.19600M 3.06M 8.06M 16.54M
Total revenue 754.30M 671.07M 646.30M 636.91M 585.99M
Total operating expenses 779.42M 707.17M 594.13M 549.45M 520.74M
Cost of revenue 584.82M 524.69M 505.85M 474.81M 53.33M
Total other income expense net 30.62M 8.85M 5.70M -144.40800M -7.50600M
Discontinued operations - - - - -
Net income from continuing ops -33.89800M -52.36200M 6.00M -116.90900M 41.29M
Net income applicable to common shares -33.89800M -52.36200M 6.00M -116.90900M 41.29M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 1869.31M 1794.97M 1866.36M 1870.32M 1894.79M
Intangible assets 82.96M 164.21M 227.58M 226.95M 222.57M
Earning assets - - - - -
Other current assets 2.19M 4.71M 13.07M 13.43M 7.15M
Total liab 1368.76M 1253.24M 1250.63M 1261.58M 1133.28M
Total stockholder equity 500.56M 541.74M 615.73M 608.75M 761.51M
Deferred long term liab - - - - -
Other current liab 1027.54M 884.07M 863.93M 836.30M 805.03M
Common stock 796.47M 795.75M 803.46M 803.36M 801.84M
Capital stock 796.47M 795.75M 803.46M 803.36M 801.84M
Retained earnings -300.95200M -257.49400M -190.35600M -196.35400M -42.13000M
Other liab - 92.50M 106.81M 103.56M 112.28M
Good will 717.61M 681.01M 681.01M 681.01M 817.07M
Other assets 1.54M 1.13M 1.10M 2.08M 2.07M
Cash 26.20M 20.41M 33.43M 30.60M 14.63M
Cash and equivalents - - - - -
Total current liabilities 1173.65M 1003.48M 968.76M 960.26M 896.00M
Current deferred revenue 126.99M 100.54M 86.74M 109.07M 76.80M
Net debt 105.46M 140.99M 146.03M 172.40M 111.67M
Short term debt 4.32M 4.15M 4.41M 5.25M 1.30M
Short long term debt 0.60M 0.47M 0.51M 1.19M 1.30M
Short long term debt total 131.66M 161.41M 179.46M 203.00M 126.30M
Other stockholder equity 0.80M 3.48M 2.63M 1.75M 1.79M
Property plant equipment 1005.75M 896.71M 904.69M 909.66M 822.70M
Total current assets 60.59M 51.91M 51.97M 50.61M 30.82M
Long term investments 0.85M 0.75M 0.75M 1.50M 1.62M
Net tangible assets - -303.48600M -292.86600M -299.21500M -278.14200M
Short term investments 0.48M - - - -
Net receivables 27.07M 10.26M 7.12M 8.13M 9.05M
Long term debt 70.00M 98.49M 113.83M 128.85M 124.60M
Inventory -0.48500M 16.53M 0.00000M 0.00000M -
Accounts payable 14.81M 14.72M 13.69M 9.64M 12.87M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 5.04M 3.48M 2.63M 1.75M 1.79M
Additional paid in capital - - - - -
Common stock total equity - - - 803.36M 801.84M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.88M 0.38M 0.35M -0.00100M -0.00100M
Deferred long term asset charges - - - - -
Non current assets total 1808.72M 1743.06M 1814.38M 1819.71M 1863.96M
Capital lease obligations 61.06M 62.45M 65.12M 72.96M -
Long term debt total 127.34M 157.25M 175.06M 197.76M 124.60M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -138.38700M -29.84200M -33.60700M -78.29500M -92.80700M
Change to liabilities 3.08M 9.46M -19.05700M 14.32M -3.00500M
Total cashflows from investing activities -138.38700M -29.84200M -33.60700M -78.29500M -92.80700M
Net borrowings - -18.61500M -19.88000M 1.12M 50.00M
Total cash from financing activities -43.31700M -38.70700M -19.88000M -31.79800M 8.31M
Change to operating activities 99.15M 27.00M 36.38M 40.37M 18.75M
Net income -33.89800M -52.36200M 5.61M -116.90900M 41.29M
Change in cash 5.79M -13.01700M 2.83M 15.97M 3.43M
Begin period cash flow 20.41M 33.43M 30.60M 14.63M 11.20M
End period cash flow 26.20M 20.41M 33.43M 30.60M 14.63M
Total cash from operating activities 187.49M 55.53M 55.32M 126.06M 87.93M
Issuance of capital stock - - - - -
Depreciation 125.93M 105.35M 41.83M 37.67M 28.72M
Other cashflows from investing activities -76.40000M 3.61M 15.43M 2.33M 0.97M
Dividends paid 9.56M 12.14M 12.14M 32.92M 41.70M
Change to inventory - - - - -
Change to account receivables -16.36300M -2.86400M 1.59M -0.83500M 2.00M
Sale purchase of stock - -7.95600M -7.95600M - -
Other cashflows from financing activities 76.24M -4.11400M 235.12M 401.12M 225.01M
Change to netincome 9.59M -31.05700M -11.27000M 142.89M 1.17M
Capital expenditures 61.99M 33.46M 49.03M 80.63M 93.78M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -16.36300M -2.86400M 1.59M -0.83500M 7.76M
Stock based compensation 1.43M 1.10M 0.98M -0.04700M -
Other non cash items 95.46M 2.54M 7.89M 205.30M -70.00900M
Free cash flow 125.51M 22.08M 6.29M 45.43M -93.78200M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EHE
Estia Health Ltd		 - -% - - 17.30 1.07 1.61 1.21 6.99
RHCPA
Ramsay Health Care Ltd Pref		 -0.13 0.12% 105.00 64.82 - 0.85 - - -
RHC
Ramsay Health Care Ltd		 -0.79 2.06% 37.63 33.39 28.57 0.53 1.85 1.17 10.70
SNZ
Summerset Group Holdings Ltd		 -0.08 0.69% 11.44 7.24 - 9.11 1.10 24.28 15.54
REG
Regis Healthcare Ltd		 -0.27 4.06% 6.38 - 24.39 1.90 259.34 1.88 9.98

Reports Covered

Stock Research & News

View All

Profile

Estia Health Limited provides residential aged care home services in Australia. It operates various residential aged care homes in New South Wales, Queensland, South Australia, and Victoria. The company was founded in 2005 and is headquartered in Sydney, Australia.

Estia Health Ltd

227 Elizabeth Street, Sydney, NSW, Australia, 2000

Key Executives

Name Title Year Born
Mr. Sean Bilton CEO, MD & Director NA
Mr. Steve Lemlin Chief Financial Officer NA
Mr. Damian Hiser Chief Operating Officer NA
Ms. Fiona Caldwell Chief Information Officer NA
Ms. Suzy Watson Gen. Counsel NA
Ms. Cath Gillard Chief People Officer NA
Ms. Leanne Laidler M.B.A., R.N. Chief Quality & Risk Officer NA
Mr. Michael Lockwood Chief Devel. & Property Officer NA
Ms. Leanne Ralph AAICD, ACIS, BBus Company Sec. NA
Mr. Mark Kennedy Devel. Mang. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.